Excluding broad-spectrum pathways such as the pathways in cancer, the results showed that prostate cancer, endocrine resistance, lipids and atherosclerosis, bladder cancer, and the IL-17 signaling pathway function in the regulation of the main components of Pule’an Tablets, which can provide reference for the subsequent study of the pharmacodynamic mechanism. Here, IL17A is linked to Familial prostate cancer.